https://wccftech.com/inovio-nasdaq-ino-stock-shoots-up-following-a-71-million-funding-by-the-u-s-dod-for-vaccine-delivery-devices/

INOVIO Pharmaceuticals (NASDAQ:INO) has secured multi-million-dollar funding from the U.S. Department of Defence (DoD) for its devices which will be used to deliver COVID-19 vaccine directly into the skin.

As per the company’s press release, the U.S. DoD has granted $71 million to INOVIO Pharmaceuticals in order to assist the biotech enterprise in scaling up the production of its Cellectra 3PSP smart device as well as the procurement of Cellectra 2000 devices intended to deliver COVID-19 vaccine candidate, INO-4800, directly into the skin.